Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Valneva (VALN)
NASDAQ:VALN
Valneva (VALN) Stock Price & Analysis
125 Followers
VALN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.07 - $17.05
Previous Close$11.29
Volume2.58K
Average Volume (3M)7.03K
Market Cap
$760.15M
Enterprise Value$643.34M
Total Cash (Recent Filing)$289.43M
Total Debt (Recent Filing)$152.38M
Price to Earnings (P/E)N/A
Beta2.31
Next Earnings
Mar 21, 2024EPS Estimate
$0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding69,183,741
10 Day Avg. Volume3,222
30 Day Avg. Volume7,034
Standard Deviation0.27
R-Squared0.25
Alpha-0.00519
Financial Highlights & Ratios
Price to Book (P/B)4.00
Price to Sales (P/S)6.81
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.57
Enterprise Value/Gross Profit-2.81
Enterprise Value/Ebitda-7.70
Forecast
1Y Price Target
$26.00Price Target Upside136.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Valneva News
Pre-EarningsValneva Se (VALN) Q2 Earnings Cheat Sheet
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
0.56% Other Institutional Investors
99.41% Public Companies and
Individual Investors
VALN FAQ
What was Valneva’s price range in the past 12 months?
Valneva lowest stock price was $9.07 and its highest was $17.05 in the past 12 months.
What is Valneva’s market cap?
Currently, no data Available
When is Valneva’s upcoming earnings report date?
Valneva’s upcoming earnings report date is Mar 21, 2024 which is in 104 days.
How were Valneva’s earnings last quarter?
Valneva released its earnings results on Nov 09, 2023. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.304 by $0.034.
Is Valneva overvalued?
According to Wall Street analysts Valneva’s price is currently Undervalued.
Does Valneva pay dividends?
Valneva does not currently pay dividends.
What is Valneva’s EPS estimate?
Valneva’s EPS estimate is $0.65.
How many shares outstanding does Valneva have?
Valneva has 69,448,300 shares outstanding.
What happened to Valneva’s price movement after its last earnings report?
Valneva reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.304. Following the earnings report the stock price went up 6.672%.
Which hedge fund is a major shareholder of Valneva?
Currently, no hedge funds are holding shares in VALN
---
Valneva Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.00 (136.36% Upside)
$26.00 (136.36% Upside)
Blogger Sentiment
Bullish
VALN Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.90%
12-Months-Change
Fundamentals
Return on Equity
-73.19%
Trailing 12-Months
Asset Growth
-19.41%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Valneva
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.
---
---